Cargando…
Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis
Chronic kidney disease (CKD) incidence is growing worldwide, with a significant percentage of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney replacement therapies (KRT). Peritoneal dialysis (PD) is a convenient KRT presenting benefices as home therapy. In PD patients, the...
Autores principales: | Trionfetti, Flavia, Marchant, Vanessa, González-Mateo, Guadalupe T., Kawka, Edyta, Márquez-Expósito, Laura, Ortiz, Alberto, López-Cabrera, Manuel, Ruiz-Ortega, Marta, Strippoli, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059714/ https://www.ncbi.nlm.nih.gov/pubmed/36982834 http://dx.doi.org/10.3390/ijms24065763 |
Ejemplares similares
-
Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
por: Terri, Michela, et al.
Publicado: (2021) -
IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis
por: Marchant, Vanessa, et al.
Publicado: (2020) -
New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis
por: Witowski, Janusz, et al.
Publicado: (2015) -
Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis
por: Loureiro, Jesús, et al.
Publicado: (2013) -
T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage
por: Liappas, Georgios, et al.
Publicado: (2015)